Send us Feedback

Deerfield Capital (DFR)
QUOTE AND NEWS
Arena Pharma gains $100M from Deerfield
FierceBiotech  Jun 17 
There's still money to be had. Arena Pharmaceuticals has gained a commitment of $100 million in funding from healthcare investors Deerfield Management. In exchange, the biotech will issue Deerfield 28 million shares of common stock at $5.42 per...
Array BioPharma lands $40M for drug programs
FierceBiotech  May 20 
Deerfield Management has agreed to provide an additional $40 million to Array BioPharma to fund its drug development work and add some fresh confidence as the developer pursues new partnership deals. That money is in addition to the $80 million...
Baxter Says Delaware Deaths Weren’t Caused by Heparin
Bloomberg  May 15 
(Update1) Baxter International Inc.’s blood thinner heparin didn’t cause deaths at a Delaware hospital, according to the company’s investigation.
Deerfield Capital Corp. Announces First Quarter 2009 Results
PR News Wire  May 11 
CHICAGO, May 11 /PRNewswire-FirstCall/ -- Deerfield Capital Corp. (NYSE AMEX: DFR) ("DFR" or the "company") today announced the results of operations for its first quarter ended March 31, 2009. FIRST QUARTER 2009 SUMMARY -- Net income for the quarter
Two Deaths Prompt Heparin Review
Wall Street Journal  May 11 
Two Delaware patients died last weekend after taking blood thinner Heparin, made by Baxter International.
[$] Walgreen Chief Sees Worst Over for Consumers
Wall Street Journal  May 7 
Walgreen CEO Gregory Wasson said sales seemed to have bottomed in January and inch up in March and April.
Home Unit Hurts Fortune Brands
Wall Street Journal  May 1 
Fortune Brands reported a 94% drop in first-quarter profit, reflecting a downturn in sales in the home-and-hardware segment amid the weak economy, as well as restructuring charges.
To Cut Costs, States Relax Prison Policies
New York Times  Mar 24 
Forced to take a more pragmatic approach, states are now seeing prisoners as expenses to be reined in.
Wind Power Big and Small
The Iconoclast Investor  Sep 15 
Nahant, the town where I live just north of Boston, is breezy in the summertime, which keeps the weather from getting as hot as on the mainland (Nahant is made up of two islands). The downside is in autumn and winter when that idyllic summer...
Deerfield Shares Driven Up By Disclosure
Mortgage REIT Journal  Apr 25 
In a rare midday press release, Deerfield Capital (DFR) disclosed some preliminary results for the quarter that were well above Street expectations, particularly the expected book value of $3.00 - $3.50, 3.5x yesterday's closing stock price. The...
Suggest other news sources for this topic
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
See All
BULLS: REASONS TO BUY
Bulls: Reasons To Buy
Feeling Bullish? Be the first to explain why this would make a good investment
See All (0)
See All
BEARS: REASONS TO SELL
Bears: Reasons To Sell
Feeling Bearish? Be the first to explain why this would make a poor investment
See All (0)
more ▼EditWIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 
DFR AT A GLANCE
 
 
 
 
 
 
 
 
Please install Flash Player to view this chart.



[edit] References

Retrieved from "http://www.wikinvest.com/stock/Deerfield_Capital_(DFR)"
 
Worried about pump and dump?
We review changes
for stock spam
» read more
Want to make Wikinvest better?
We need your help,
contribute today
» learn how
Do you write software?
We are recruiting
the best engineers
» view jobs
Like Wikinvest?
Spread the word —
Tell your friends!
» spread the word
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki